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The aim of this study was to develop a vitrification procedure for human ovarian tissue cryopreservation in order to better preserve
the ovarian tissue. Large size samples of ovarian tissue retrieved from 15 female-to-male transgender subjects (18–38 years) were
vitrified using two solutions (containing propylene glycol, ethylene glycol, and sucrose at different concentrations) in an open
system. Light microscopy, transmission electron microscopy, and TUNEL assay were applied to evaluate the efficiency of the
vitrification protocol. After vitrification/warming, light microscopy showed oocyte nucleus with slightly thickened chromatin and
irregular shape, while granulosa and stromal cells appeared well preserved. Transmission electron microscopy showed oocytes
with slightly irregular nuclear shape and finely dispersed chromatin. Clear vacuoles and alterations in cellular organelles were
seen in the oocyte cytoplasm. Stromal cells had a moderately dispersed chromatin and homogeneous cytoplasm with slight
vacuolization. TUNEL assay revealed the lack of apoptosis induction by vitrification in all ovarian cell types. In conclusion after
vitrification/warming the stromal compartmentmaintainedmorphological and ultrastructural features similar to fresh tissue, while
the oocyte cytoplasm was slightly damaged. Although these data are encouraging, further studies are necessary and essential to
optimize vitrification procedure.
1. Introduction
Ovarian tissue cryopreservation and its storage offer the hope
to prepubertal girls or fertile age women who suffer from
benign or malignant disease and want to safeguard their
ovarian function against the hazardous effects of surgery,
chemotherapy, and radiotherapy.
Despite the encouraging results much can still be done
to minimize tissue damage during the cryopreservation
procedure. It is known that the cryopreservation procedure
leads to a loss in the follicular pool when compared with
fresh ovarian tissue [1]. This result is principally due to ice
crystal formation during the cryopreservation procedures,
which can have a deleterious effect on cellular interactions
and cell membranes [2].
Cryopreservation of ovarian tissue is primarily per-
formed by slow freezing/rapid thawing for human fertility
preservation and 24 live births and 4 ongoing pregnancies
have been obtained after transplantation with this technique
[3]. However, many studies have emphasized that the slow
freezing of ovarian tissue safeguards the smallest follicles in
the tissue, while it determined the greatest damage in the
stroma cells [4, 5].
An emerging alternative procedure for the cryopreserva-
tion of ovarian tissue is represented by vitrification/warming.
The vitrification is an ultrarapid cooling process that pro-
duces a glass-like solidification of cells by extreme elevation
in viscosity, so as to avoid cellular injury caused by ice crystal
formation [6–10]. In order to achieve successful vitrification,
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high cooling rates, as well as high concentrations of cryopro-
tectants are required.
This method has been successfully applied to preserve
human blastocyst and oocyte [11, 12]. For ovarian tissue,
good results have been reported in rodents, domestic animals,
nonhuman primates, and human; even if, data on human
ovarian tissue vitrification are still limited [13].
The aim of this study was to develop a vitrification pro-
cedure for human ovarian tissue cryopreservation in order to
better preserve the ovarian tissue.
2. Materials and Methods
2.1. Patients. The study was conducted in 15 female-to-male
transgender subjects (FTMs), 18–38 years, (28.19 ± 5.51,
mean age ± standard deviation) suffering from gender iden-
tity disorder and undergoing sex reassignment surgery by
hysterectomy-ovariectomy (Clinical trial n∘61/2007/O/Tess)
at Gynecology and Pathophysiology of Human Reproduc-
tion Unit, University of Bologna, Italy. The patients have
donated their ovarian tissue for research. For each patient
ovarian tissue samples were analyzed at the time of sample
collection (fresh tissue, t0) and after vitrification/warming
(vitrified/warmed tissue, t1). t1 sample was compared with
t0 sample of the same patient to minimize the interpatient
variation.
2.2. Tissue Sampling. For each patient, a bioptic ovarian
sample was collected at the time of surgery and immediately
transferred to the laboratory in a Dulbecco’s phosphate
buffered solution (PBS) (Gibco, Life Technologies LTD, Pais-
ley, Scotland) with 10% inactivated human serum (provided
by the Transfusion Centre of S.Orsola-Malpighi Hospital
of Bologna, Italy). Bioptic ovarian sample was cut into
slices 1,5 × 0,5 × 0,2 cm with a scalpel blade, placed
in precooled plastic cryovials (Intermed Nunc Cryotubes,
Roskilde, Denmark) and cryopreserved using the vitrifi-
cation/warming protocol. For each patient, three samples
(3mm2) were processed for light microscopy, transmission
electron microscopy, and TUNEL assay (fresh tissue, t0).
2.3. Vitrification/Warming Protocol
2.3.1. Vitrification Protocol. The vitrification protocol was
based on a two-step method in an open carrier. Each
ovarian sample was placed in a cryovial containing 1.8mL
of equilibration solution consisting of 2M propylene glycol
(Fluka Chemical, Sigma Aldrich, SrL, Milan, Italy) + 3M
ethylene glycol (Fluka Chemical, Sigma Aldrich, SrL, Milan,
Italy) + 0.2M sucrose (Fluka Chemical, Sigma Aldrich, SrL,
Milan, Italy) + 15% human serum in PBS and was transferred
to a rolling system at 4∘C for 30min. Subsequently, the sample
was transferred into a second cryovial containing 1.8mL of
vitrification solution consisting of 3Mpropylene glycol + 5M
ethylene glycol + 0.5M sucrose + 15% human serum in PBS
and newly put onto a rolling system at 4∘C for 30min. Then,
the sample was loaded in 200𝜇L of vitrification solution on
an open plastic support and quickly immersed into liquid
nitrogen decontaminated according to Parmegiani protocol
[14]. Following, the support containing the samplewas placed
in an empty cryovial (Intermed Nunc Cryotubes, Denmark)
and stored into a liquid nitrogen tank for at least 1-2 months
before warming.
2.3.2. Warming Protocol. The support containing the sample
was released from the cryovial, exposed at room tempera-
ture for 30 sec, and then immersed in a warming solution
consisting of 1M sucrose + 15% human serum in PBS at
39∘C for 1min, gently shaking until the ice was completely
melted. Subsequently, the cryoprotectant was removed at 4∘C
by stepwise dilution of sucrose. The sample was transferred
to the solution 1 (0.5M sucrose + PBS + 15% human serum)
for 3min, and then to the solution 2 (0.25M sucrose +
15% human serum in PBS) for 3min. Finally, the warmed
sample was rinsed in preequilibrated 𝛼 minimal essential
medium (𝛼-MEM, Sigma Aldrich SrL; Milan, Italy) sup-
plemented with penicillin/streptomycin (0.1mg/mL) + 10%
human serum two times at 4∘C for 1min. For each patient,
warmed sample was fixed for the same analysis conducted on
fresh sample (warmed tissue, t1).
2.4. Light and Transmission Electron Microscopy. For each
patient, fresh and vitrified/warmed samples were fixed in
a 4% paraformaldehyde solution in distilled water main-
tained at pH 7.4 overnight at 4∘C. After osmium tetrox-
ide postfixation and alcohol dehydration, the samples were
embedded in epoxy resin (AralditeMhardener, Fluka, Buchs,
Switzerland) and then sectioned using an ultramicrotome
(Ultracut, Reichert, Vienna, Austria). For each sample, one
0.5 𝜇m thick section out of every 50 was collected and stained
with toluidine blue. Sections were initially observed under a
microscope (Nikon) at ×10 magnification to detect artifacts
and discharge samples without cortical tissue. Sections were
then observed at ×25 to establish the development stage of
the follicle, according to Gougeon classification [15], and
to evaluate architecture and nuclear and cytoplasm features
of stromal cells. Finally, sections were analysed at ×40 to
evaluate follicle and interstitial injury on at least 10 random
microscopic high power fields (HPF) and scored using the
method previously described by Fabbri et al. [5]. Semithin
sections were viewed in a blind fashion by two different
pathologists using a Leitz Diaplan light microscope equipped
with a CCD JVC video camera, and digitized images were
analyzed with Image ProPlus software.
After semithin sectioning, the 60 nm thick sections were
collected on 200 mesh grids, stained with uranyl acetate
followed by lead citrate and viewed using a Philips 410
T transmission electron microscope at 80 kV, in order to
evaluate the ultrastructural features of follicles before and
after vitrification/warming. Chromatin pattern, integrity of
organelles, and membranes were carefully screened for
oocytes, granulosa as well as stromal cells, according to
previously reported subcellular criteria [5].
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Table 1: Number and % of degenerated follicles on the total number of follicles parted for primordial, primary, secondary, preantral, and
antral stage.
Samples
(𝑛 = 15)
Degenerated follicles/total number of follicles (%)
Primordial/intermediary Primary Secondary Preantral Antral TOT.
t0 215/739 (29) 4/15 (27) 1/2 (50) 0/1 (0%) 0/0 (0%) 757
t1 221/690 (32) 9/28 (32) 1/3 (33) 0/0 (0%) 0/1 (0%) 722
t0: fresh tissue; t1: vitrified/warmed tissue.
25𝜇m
(a)
25𝜇m
(b)
Figure 1: Lightmicroscopy images of t0 (a) and t1 (b) samples.Well-preserved clusters of follicles displaying euchromatic nuclei and preserved
oocyte cytoplasm. Compact stromal cells. t0 = fresh tissue and t1 = vitrified/warmed tissue.
2.5. Apoptosis Analysis. For each patient, fresh and vitri-
fied/warmed sampleswere fixed in 4% formaldehyde, embed-
ded in paraffin, and serially sectioned at a thickness of 4 𝜇m.
Every 5 slides, one was stained with haematoxylin and eosin
(Merck KGaA, Darmstadt, Germany) for histological eval-
uation; the other slides were TUNEL stained, for apoptosis
evaluation (POD, Roche, Mannheim, Germany), according
to the manufacturer’s instructions. Brown nuclei indicated
TUNEL-positive cells. Follicles with more than two TUNEL-
positive granulosa cells were considered to be apoptotic, as
well as those follicles with TUNEL-positive oocytes. A total of
100 follicles were analyzed for each experimental condition.
The number of apoptotic stromal cells was analyzed in a
100 𝜇m2 square (randomly assigned in the sections) and was
counted three times and then averaged. The percentage of
apoptotic cells was calculated as follows: apoptotic cell num-
ber/total cell number × 100 and quantified in a double blind
fashion using a Leitz Diaplan light microscope equipped with
a CCD JVC video camera. Digitized images were analyzed
with Image ProPlus software.
2.6. Statistical Analysis. For each variable (follicle damage
and interstitial edema), at least 10 fields were scored on
an integer scale of 0–3. Differences in the mean score
among fresh and vitrified/warmed samples were statistically
analyzed usingKruskal-Wallis test followed byDunnmultiple
comparison test (GraphPad Prism version 4). The Student’s
𝑡-test was used to analyze the percentage of apoptotic cells
observed in fresh and vitrified/warmed samples (GraphPad
Prism version 4). 𝑃 < 0.05 was considered statistically
significant.
3. Results
3.1. Light and Transmission Electron Microscopy. A total of
1479 follicles (from fresh and vitrified/warmed samples) were
analyzed by light microscopy to evaluate the morphology,
the developmental stage, and the percentage of degenerated
follicles on the total number of follicles (Table 1).The number
of follicles was equally distributed among fresh and vitri-
fied/warmed samples (53% versus 47%; 𝑃 = 0.905). The
follicle density (follicle number permm2 of the overall section
area) was 4.28 ± 6.15/mm2 in fresh and 4.12 ± 6.48/mm2 in
vitrified/warmed tissue (𝑃 = 0.269). Overall, 1429 follicles
(96.5%) were primordial and intermediary, 43 (3%) primary,
5 (0.36%) secondary, 1 (0.07%) preantral, and 1 (0.07%) antral.
In fresh samples follicles showed close adherence between
oocyte and granulosa cells with normal morphological
appearance: the oocytes had many mitochondria located
around the nucleus, homogenous cytoplasm, and no vacuoles
were observed. Stromal cells had oval- to spindle-shaped
nucleus with a finely dispersed chromatin, small cytoplasm
vacuoles were seen, and no interstitial edema was present
(Figure 1(a)).
The vitrified samples showed oocyte nucleus with slightly
thickened chromatin and irregular shape, while granulosa
cells were well preserved. The architecture of the ovarian
stromal was intact, maintaining the features of not vitrified
tissue even though an increased cytoplasm vacuolization was
observed (Figure 1(b)).
The data obtained by statistical analysis showed that no
significant differences were observed in the overall preserva-
tion of ovarian tissue processed according to the vitrification
protocol when compared with fresh tissue (Figure 2).
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Figure 2: Statistical analysis, showing scores for follicle and stroma
preservation in fresh (t0) and vitrified/warmed (t1) ovarian cortical
tissue. Values are expressed as mean ± SD. Score interpretation:
0 = good preservation, 1 = poor preservation, 2 = bad preservation,
and 3 = worst preservation. 𝑃 = 0.17 for stroma and 𝑃 = 0.53 for
follicles.
To extend and validate LM evaluation, ultrastructural
analysis was performed. A total of 132 follicles, equally
distributed among fresh and vitrified/warmed samples (70
versus 62, 𝑃 = 0.712), were analyzed. The fresh samples
showed follicles containing large oocytes with regular nuclei,
finely dispersed chromatin, nuclear pores, and abundant
cytoplasm. Mitochondria appeared typically rounded, with
a low-density matrix and few peripheral cristae, clustered in
clouds or arranged in a rosette-like pattern around a dense,
amorphous or finely granular intermitochondrial substance.
Golgi apparatus was well developed; a few cisternae of
rough endoplasmic reticulum were seen and occasional lipid
inclusions and lipofuscin bodies as well. A close adhesion
between oocyte and follicular cells was commonly seen.
Granulosa cells showed flat nuclei with one or two reticular
nucleoli. Rod-shaped mitochondria, free ribosomes, rough
and smooth endoplasmic reticulum, and scattered vacuoles
were observed in the cell cytoplasm (Figure 3(a)).The stroma
showed spindle cell with moderately dispersed chromatin
andhomogeneous cytoplasmand slight signs of vacuolization
(Figure 3(b)).
The vitrified/warmed follicles had nucleus with slight
irregular shape and finely dispersed chromatin. Clear vac-
uoles were seen in the oocyte cytoplasm and a slight clarifica-
tion of the cytoplasmicmatrix as well. Cytoplasmic organelles
were altered in shape and distribution. Irregularly shaped or
swollen mitochondria were found scattered in the cytoplasm
or around large vacuoles. Granulosa cells were adherent
to oocyte (Figure 3(c)). Stromal cells showed moderately
dispersed chromatin and homogeneous cytoplasmwith slight
vacuolization and enlarged mitochondria (Figure 3(d)).
3.2. TUNEL Assay. Only follicles with a visible oocyte
nucleus were analyzed. The percentage of apoptotic follicles
was 5% and 6% in fresh and vitrified/warmed samples,
respectively (𝑃 = 0.13). The percentage of DNA damaged
stromal cells evaluated in fresh and vitrified/warmed samples
was 11% and 12%, respectively (𝑃 = 0.18; Figure 4).
4. Discussion
Today the cryopreservation of ovarian tissue before the start
of cancer treatments is proposed as an option for preserving
fertility. It allows recovering of a large number of follicles; it
may be performed at any time of themenstrual cycle avoiding
delay in the onset of antineoplastic therapy; it is particularly
indicated in patients with hormone-related cancers, and it is
the only option for prepubertal patients [3].
The critical points in the cryopreservation of ovarian
tissue are determined by the presence of heterogeneous cellu-
lar components (oocytes, granulosa, and stromal cells) with
different properties, which make the osmotic dehydration
and rehydration extremely variable [16].
Cryopreservation strategies for ovarian tissue have there-
fore aimed to optimize methods and protocols for the
preservation of whole tissue [13].
In the last decade there has been a great interest for the
vitrification, since it might prevent tissue damage due to ice
crystal formation. The success of vitrification depends on
many factors such as sample size, type and concentration
of cryoprotectants, temperature of exposure to vitrification
solution, stepwise addition of vitrification solution, carrier
system, quality of samples, and technical expertise [13].
Because of so many variables, the results obtained from
vitrification are discrepant from species to species and within
the same species [13].
The vitrification of ovarian tissue in animal models
(mouse, sheep, ovine, bovine, monkey, hamster, rabbit, and
baboon) has produced promising results: follicles maintain
the same survival rates, morphology, and ultrastructure
comparable to fresh follicles, yielding even live births in some
species [3, 13].
In human, many studies support vitrification as the
method of choice for ovarian tissue cryopreservation, pro-
viding similar results to conventional freezing, with the addi-
tional advantage of preserving the ultrastructure of stromal
tissue that is usually affected by freezing [1, 2, 13, 17–19].
However the live birth of babies from transplantation of
vitrified ovarian tissue has not yet been obtained. Therefore,
despite the encouraging results, absolute conclusions cannot
easily be drawn.
In our study large size samples and two solutions were
used to vitrify human ovarian tissue in an open system. In
order to promote the dehydration of large size samples, a
combination of ethylene glycol, propylene glycol, and sucrose
at different concentrations and a long equilibration time were
applied. Light and transmission electron microscopy and
TUNEL analysis were applied tomonitor the efficiency of our
vitrification protocol.
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Figure 3: Ultrastructure images of t0 ((a), (b)) and t1 ((c), (d)) ovarian cortical tissue. A primordial follicle with a layer of flattened
granulosa cells. The oocyte nucleus shows homogeneous euchromatin surrounded by the nuclear membrane. Cytoplasm is well organized
with perinuclear round mitochondria (a). Spindle stromal cells with moderately dispersed chromatin and homogeneous cytoplasm (b). A
primary follicle with a layer of cuboidal granulosa cell firmly attached to the oocyte. The oocyte nucleus has a slight irregular outline and
euchromatin content. Mitochondria are eccentrically placed at one side of the oocyte cytoplasm (c). Stromal cells have moderately dispersed
chromatin, compact cytoplasm with enlarged mitochondria (d). t0 = fresh tissue and t1 = vitrified/warmed tissue.
25𝜇m
(a)
25𝜇m
(b)
Figure 4: TUNEL images of t0 (a) and t1 (b) samples. t0 = fresh tissue and t1 = vitrified/warmed tissue.
The literature data show that the sample’s sizes have a
strong influence on the preservation; in fact using small spec-
imens with better results has been obtained [13]. However
studies in sheep by Bordes group [20] obtained the birth of
four lambs and the recovery of ovarian endocrine function by
half ovary vitrification [20, 21]. In addition, data reported by
Ferreira et al. [22] on bovine ovarian cortex showed that there
was an increased risk of morphological damage to primary
and primordial follicles when the tissue slices were cut with
all dimension larger than 2mm, provided that one of the
dimensions of the fragment slice is maintained ≤2mm [22].
The vitrification of large size samples of human ovarian tissue
could be particularly useful, because the handling of the tissue
and the gain in terms of follicular population are better using
the larger samples [23].
Our results show that after vitrification/warming the stro-
mal compartment maintains morphological and ultrastruc-
tural features similar to those seen in fresh tissue. Regarding
follicles, the granulosa cells appear well preserved, while the
oocyte appears slightly negatively affected by vitrification,
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as shown by increased cytoplasm vacuolization and organelle
changes. These features might be considered as early signs of
follicular degeneration, likely due to an inadequate dehydra-
tion and/or osmotic stress [24].
Our results are in agreement with those reported by other
authors [25–28]. Gandolfi et al. [25] showed that vitrification
caused extensivemorphological damage to primordial follicle
in human ovarian tissue. Isachenko et al. [26] compared
conventional freezing and vitrification of human ovarian
tissue in terms of follicular quality, steroidogenic activity,
and proliferative potential by GAPDH gene expression. The
results provided evidence that conventional freezing allowed
a better preservation of all types of follicles and a higher pro-
liferative capacity of the tissue than vitrification, concluding
that conventional freezing is the method of choice for the
cryopreservation of human ovarian tissue. Irregularly shaped
or swollen mitochondria scattered in the cytoplasm of both
oocytes and follicular cells were reported by Zhou et al. [27]
using conventional vitrification. Oktem et al. [28] reported
that vitrified ovaries contained statistically significantly fewer
primordial follicles and reported statistically significantly less
hormonal production in vitro when compared with fresh and
slow-frozen ovaries.
In the present study we also evaluated the frequency
of apoptosis in ovarian tissue after vitrification. In agree-
ment with previous studies, TUNEL assay does not show
evidence of any statistical difference in apoptosis between
fresh and vitrified samples [17, 18]. This finding suggests
that the cryodamages induced by vitrification occur mainly
in cytoplasmic organelles and cell membranes, preserving
the nuclear compartment. In fact, at nuclear level the most
likely consequence of vitrification would be the necrosis
process, which can be better demonstrated using careful
morphological and ultrastructural analysis [16].
Certainly a limitation of the present study has been
the lack of functional tests that allowed determining if the
damage done to oocytes was reversible and transitory or
not. Further investigation such as xeno-transplantationmight
give information about viability of the follicle within the
tissue. Nevertheless, tissue culture might be an excellent
alternative method to demonstrate the viability of the tissue.
5. Conclusions
In conclusion, our vitrification protocol showed a good
preservation of the stromal compartment, as also reported
by other authors in the literature. This finding indicates
that vitrification protocols are efficient for human ovarian
tissue cryopreservation compared with conventional freez-
ing, because stromal damages are avoided. However, in our
study slight damages to the oocytes were observed after
vitrification. Therefore, further studies are necessary and
essential to optimize the vitrification protocol and to decide
to switch from conventional freezing to vitrification for
human ovarian tissue cryopreservation. The final proof to
propose vitrification of ovarian tissue to patients will only
be the birth of healthy babies after reimplantation of vitrified
tissue.
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